Filter
715
Filtered Results: 715
Text search:
World
Health
Organization,
Office
Myanmar
Featured
Recommendations
61
New Publications
271
Language
Document type
No document type
457
Studies & Reports
129
Guidelines
60
Manuals
32
Strategic & Response Plan
20
Situation Updates
6
Infographics
3
Fact sheets
3
Training Material
2
Brochures
1
Resource Platforms
1
Online Courses
1
Countries / Regions
Myanmar / Burma
143
Bangladesh
45
Global
44
South–East Asia Region
36
Asia
34
India
14
Indonesia
11
Nepal
10
Thailand
8
Philippines
8
Syria
6
Cambodia
6
Western and Central Europe
6
Laos
5
Congo, Democratic Republic of
5
Yemen
5
Ethiopia
5
Kenya
4
Nigeria
4
Africa
4
Ukraine
3
Afghanistan
3
Malawi
3
Malaysia
3
Latin America and the Carribbean
3
Vietnam
3
Central African Republic
3
South Sudan
3
Somalia
3
Colombia
2
Burkina Faso
2
Mozambique
2
Tanzania
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
South Africa
2
Sri Lanka
2
Sudan
2
Mali
2
Pakistan
2
Tajikistan
1
North Korea
1
Timor Leste/ East Timor
1
Mexico
1
Ghana
1
Sierra Leone
1
Cameroon
1
Singapore
1
Mongolia
1
Armenia
1
Haiti
1
Venezuela
1
Jordan
1
West and Central Africa
1
Middle East and North Africa
1
Turkmenistan
1
East and Southern Africa
1
Uganda
1
Brazil
1
Russia
1
Palestine
1
Libya
1
Bhutan
1
Iraq
1
Liberia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
223
Clinical Guidelines
49
Women & Child Health
46
Key Resources
40
Public Health
36
Capacity Building
11
Pharmacy & Technologies
8
Toolboxes
HIV
90
Mental Health
65
TB
53
COVID-19
35
Disability
28
Conflict
24
Rapid Response
23
Planetary Health
22
Natural Hazards
19
Global Health Education
19
Refugee
15
NTDs
15
AMR
12
Pharmacy
7
Specific Hazards
5
Health Financing Toolbox
5
Polio
5
Caregiver
4
NCDs
3
Ebola
2
Typhoon
2
Zika
1
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem...
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta...
Fact Sheet Global Atlas of medical devices
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
This purpose of this guide is to inform robust evaluations of the WHO training package – a package aimed at personnel whose primary role in health-care facilities is environmental cleaning, hereafter referred to as cleaners.
The WHO training package – Environmental cleaning and infection prev...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
Second editon
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr...
This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...
A sanitary inspection is a simple, on-site evaluation (traditionally using a checklist) to help identify and support the management of priority risk factors that may lead to contamination of a drinking-water supply. Sanitary inspections are a well-established and widely-applied practice. They can su...
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o...
The HIV drug resistance report 2021 summarizes findings from 38 countries that had finalized the surveys by the time of this report and shared data with WHO.
Pretreatment HIVDR to non-nucleoside reverse-transcriptase inhibitors (NNRTI) can affect more than 10% of adults starting therapy and is fo...
The Guidance on global monitoring for diabetes prevention and control by WHO provides a comprehensive framework to support countries in tracking and managing diabetes prevention, care, and outcomes. This document outlines indicators across 4 domains: health system determinants, service delivery, ris...
